公司概覽
業務類別 --
業務概覽 Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the developmentof novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.
公司地址 Ziegelhauser Landstrabe 3, Heidelberg, BW, DEU, 69120
電話號碼 +49 6221 6492487
傳真號碼 +49 6221 6492472
公司網頁 https://www.epigenomics.com
員工數量 2
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
沒有相關資料。
 
所屬ETF (更新日期: 24/02/2024 02:07)
代號 名稱 佔比% 持有日期
SPDWSPDR® Portfolio Developed Wld ex-US ETF0.0003%11/10/2018
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.